2024 State of Pharma Services and IT
2024 State of Pharma Services and IT
1 PagesPharma services and IT providers face a challenging environment as clinical leaders operate under intense budget pressure. Clinical trial activity has fallen by about 10 percent annually since 2021, and a return to earlier peak levels is expected to take years, if it happens at all. As a result, sponsors are scrutinizing clinical budgets more closely and carefully managing services spending. In this constrained market, life sciences service providers that understand these dynamics have more options to protect performance, limit exposure, and adapt their offerings to better align with tighter sponsor priorities and evolving demand.
